Appointment of Nominated Adviser and Broker
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your DXRX notes
Belfast and London, 2 September 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry is pleased to announce the appointment of Canaccord Genuity Limited as the Company's Nominated Adviser and Broker, with immediate effect.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.